About this trial
This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥19 years
Diagnosed with pulmonary TB and either initiating or undergoing treatment or history of treated pulmonary TB
Disqualifiers
Age <19 years
Extrapulmonary TB without lung involvement
Refusal to provide informed consent
Trial population
Adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
respiratory symptoms
Prevalence and progression of respiratory symptoms (mMRC score, cough, sputum, hemoptysis)
abnormal radiographic findings
abnormal findings of chest X-ray or chest CT
pulmonary function
Pulmonary function measured by spirometry: FEV1, FVC, FEV1/FVC
Quality of life
Quality of life measured by EQ-5D-5L, PROMIS, SGRQ
Secondary outcomes
poor long-term outcome
Association of poor long-term outcomes with demographic and clinical variables (age, sex, BMI, comorbidities)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.